107 related articles for article (PubMed ID: 7327218)
1. Influence of the immunomodulating compound BM 12.531 (azimexone) on radioresistance and granulopoietic colony forming units in mice.
Gassel WD; Laukel H; Braun R; Werner T; Bicker U
Exp Pathol; 1981; 20(2):105-7. PubMed ID: 7327218
[TBL] [Abstract][Full Text] [Related]
2. The influence on the formation of unstable haemoglobin by the immunomodulating 2-cyanaziridines azimexone and BM 41.332 in mice.
Isert B; Mengel K; Bicker U; Friedberg KD
J Immunopharmacol; 1985; 7(2):179-93. PubMed ID: 4031509
[TBL] [Abstract][Full Text] [Related]
3. The action of azimexone on the cells of the hemopoietic system in mice, especially after damage with X-rays.
Friedberg KD; Mengel K; Schlick E
Radiat Environ Biophys; 1983; 22(2):117-31. PubMed ID: 6611846
[TBL] [Abstract][Full Text] [Related]
4. Effect of the immune modulators BM 12.531 (azimexone) and BM 41.332 on the subsets of T-lymphocytes in mice.
Olsson L; Bicker U
J Immunopharmacol; 1981-1982; 3(3-4):277-88. PubMed ID: 6215448
[TBL] [Abstract][Full Text] [Related]
5. Effect of azimexon (BM 12.531) on mouse granulocyte-macrophage and monocyte-macrophage progenitor cells.
Jeng JC; McCarthy KF; Chirigos MA; Weiss JF
Experientia; 1982 Jan; 38(1):132-4. PubMed ID: 7056357
[TBL] [Abstract][Full Text] [Related]
6. Influence of cyclophosphamide (Endoxan) and azimexone (BM 12.531), 2-[2-Cyanaziridinyl-(1)]-2-[2-carbamoylaziridinyl-(1)]-propane, on the bone marrow cells of mice.
Adam M; Ernst H; Bicker U
Exp Pathol; 1981; 19(1):1-14. PubMed ID: 7262269
[No Abstract] [Full Text] [Related]
7. Modulation of myelopoiesis by CSF or CSF-inducing biological response modifiers.
Schlick E; Ruffmann R; Hartung K; Chirigos MA
J Immunopharmacol; 1985; 7(1):141-66. PubMed ID: 3874241
[TBL] [Abstract][Full Text] [Related]
8. Effects of BM 12,531 (azimexon) on in vitro lymphocyte and macrophage proliferation.
Hadden JW; Coffey RG
Recent Results Cancer Res; 1980; 75():162-4. PubMed ID: 7232828
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by the new synthetic compound BM 12.531, 2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone).
Luckenbach GA; Cortez-Campeao D; Modolell ML; Munder PG; Bicker U
Exp Pathol; 1981; 19(1):37-48. PubMed ID: 7262272
[No Abstract] [Full Text] [Related]
10. Radioprotective effects of combination broncho-vaxom, a macrophage activator, and indomethacin, an inhibitor of prostaglandin production: relationship to myelopoiesis.
Fedorocko P; Macková O
Eur J Haematol; 1996; 56(1-2):54-61. PubMed ID: 8599994
[TBL] [Abstract][Full Text] [Related]
11. [Effects of azimexon on interleukin 2 and interleukin 1 production in vitro].
Song JP; Qian DH
Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):468-71. PubMed ID: 3265267
[No Abstract] [Full Text] [Related]
12. Ex vivo culture rescues hematopoietic stem cells with long-term repopulating capacity following harvest from lethally irradiated mice.
Chute JP; Fung J; Muramoto G; Erwin R
Exp Hematol; 2004 Mar; 32(3):308-17. PubMed ID: 15003317
[TBL] [Abstract][Full Text] [Related]
13. Different effect of two immunomodulating agents cyclosporin A and ciamexon on the insulin metabolism of cultured mouse islets.
Linn T; Germann H; Bretzel RG; Helmke K; Bicker U; Federlin K
Diabetes Res; 1987 Mar; 4(3):121-3. PubMed ID: 3038453
[TBL] [Abstract][Full Text] [Related]
14. Reduction of acute toxicity of cyclophosphamide and X-rays by the new immunomodulating compound BM 12.531.
Bicker U; Friedberg KD; Hebold G; Mengel K
Experientia; 1979 Oct; 35(10):1361-3. PubMed ID: 499423
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulating effects of BM 12.531 in animals and tolerance in man.
Bicker U
Cancer Treat Rep; 1978 Nov; 62(11):1987-96. PubMed ID: 728913
[TBL] [Abstract][Full Text] [Related]
16. In vivo immunomodulating properties of two synthetic agents: azimexon and tuftsin.
Florentin I; Schulz J; Bruley-Rosset M; Kiger N; Martinez J; Mathé G
Recent Results Cancer Res; 1980; 75():153-61. PubMed ID: 6894500
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing and cytotoxicity studies with CB 1954 (2,4-dinitro-5-aziridinylbenzamide).
Stratford IJ; Williamson C; Hoe S; Adams GE
Radiat Res; 1981 Dec; 88(3):502-9. PubMed ID: 7313077
[No Abstract] [Full Text] [Related]
18. Administration of the bacterial extract Broncho-Vaxom enhances radiation recovery and myelopoietic regeneration.
Fedorocko P; Macková NO; Brezáni P; Kopka M
Immunopharmacology; 1994; 28(2):163-70. PubMed ID: 8002290
[TBL] [Abstract][Full Text] [Related]
19. Combined radioprotective effect of Broncho-Vaxom and WR-2721 on hemopoiesis and circulating blood cells.
Macková NO; Fedorocko P
Neoplasma; 1995; 42(1):25-30. PubMed ID: 7617070
[TBL] [Abstract][Full Text] [Related]
20. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
Grant S; Pettit GR; McCrady C
Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
